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1270Objective: The study objective was to develop a risk model incorporating diagnostic information to adjust for
case-mix severity during routine monitoring of outcomes for pediatric cardiac surgery.
Methods: Data from the Central Cardiac Audit Database for all pediatric cardiac surgery procedures performed
in the United Kingdom between 2000 and 2010 were included: 70% for model development and 30% for val-
idation. Units of analysis were 30-day episodes after the first surgical procedure. We used logistic regression for
30-day mortality. Risk factors considered included procedural information based on Central Cardiac Audit Da-
tabase ‘‘specific procedures,’’ diagnostic information defined by 24 ‘‘primary’’ cardiac diagnoses and ‘‘univen-
tricular’’ status, and other patient characteristics.
Results:Of the 27,140 30-day episodes in the development set, 25,613 were survivals, 834 were deaths, and 693
were of unknown status (mortality, 3.2%). The risk model includes procedure, cardiac diagnosis, univentricular
status, age band (neonate, infant, child), continuous age, continuous weight, presence of non–Down syndrome
comorbidity, bypass, and year of operation 2007 or later (because of decreasing mortality). A risk score was
calculated for 95% of cases in the validation set (weight missing in 5%). The model discriminated well; the
C-index for validation set was 0.77 (0.81 for post-2007 data). Removal of all but procedural information
gave a reduced C-index of 0.72. The model performed well across the spectrum of predicted risk, but there
was evidence of underestimation of mortality risk in neonates undergoing operation from 2007.
Conclusions: The risk model performs well. Diagnostic information added useful discriminatory power. A fu-
ture application is risk adjustment during routine monitoring of outcomes in the United Kingdom to assist qual-
ity assurance. (J Thorac Cardiovasc Surg 2013;145:1270-8)Since one UK center experienced a number of ‘‘excess
deaths’’ in children after cardiac surgery,1 a culture of audit
and quality improvement has emerged in the United King-
dom, with particular interest in monitoring outcomes and
center performance within pediatric cardiac surgery.2,3 A
major review of pediatric cardiac surgery services in the
United Kingdom4 recently stressed the need for national
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The Journal of Thoracic and Cardiovascular Surmeaningful. Yet to do such routine monitoring fairly and ef-
fectively, one needs to account for the case mix of each cen-
ter.5 Adjusting for risk in pediatric cardiac surgery is
challenging because of the diversity of the patient popula-
tion in terms of the diagnoses, operations performed, age
at operation, and other factors.6
A worldwide effort to collect data for quality assurance
and benchmarking7-9 has seen the evolution of a number of
multi-institutional databases. This activity has been under-
pinned by ongoing work on congenital cardiac diagnostic
and procedural coding toward the development of univer-
sally applicable codes to describe the pediatric cardiac
case mix.10-12 Accrual of standardized data on case mix
and outcomes has led to a shift from the use of consensus-
based risk stratification tools (eg, RACHS-1 [Risk Adjust-
ment for Congenital Heart Surgery-1] categories13 and
Aristotle Basic Complexity Levels [ABC Levels]14) to risk
estimates based on empirical data.15 Of note, this previous
work has focused on outcomes according to the procedure
performed, without account taken of the range of cardiac
diagnoses for which some procedures are performed.
The current article reports the development of the Partial
Risk Adjustment in Surgery (PRAiS) model for pediatric
cardiac surgery, which is based on empirical data, withgery c May 2013
Abbreviations and Acronyms
CCAD ¼ Central Cardiac Audit Database
EACTS ¼ European Association for
Cardio-Thoracic Surgery
IPCCC ¼ International Paediatric and Congenital
Cardiac Code
STS ¼ Society of Thoracic Surgeons
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Dprocedural information augmented by information on car-
diac diagnosis in addition to age, weight, and comorbidities.
The motivation was to develop a model fit for the purpose of
adjusting for case-mix severity during routine monitoring of
short-term outcomes after pediatric cardiac surgery in the
United Kingdom.
MATERIALS AND METHODS
Data Source and Study Population
The pseudonymized dataset used in this study was provided by the Cen-
tral Cardiac Audit Database (CCAD).16 Since 2000, mandatory data sub-
missions to CCAD have been requested every 3 months from all
hospitals performing cardiac surgery in the United Kingdom, including
details about patient diagnoses and comorbidities, and the operation per-
formed. The data are validated and subject to a quality assurance process,
with all units undergoing annual inspection in which local records are ex-
amined to ensure every case performed in the center has been submitted
and a random sample of case notes is examined in detail to assess data qual-
ity.9 Patients’ survival status is independently verified through periodic re-
quests to the National Health Service Central Register, as approved by the
National Information and Governance Board for Health and Social Care,
with consent requested from patients/parents for participation in national
audit of outcomes.
The data used concerned surgical operations conducted before October
31, 2010, in patients aged less than 16 years. Official transition to adult ser-
vices in the United Kingdom occurs at 16 years of age, and guidelines rec-
ommend the treatment of individuals aged 16 years or more to be in an adult
center. The dataset was then split into development (70% of patients) and
validation (30% of patients) samples using random allocation stratified by
year and institution of first procedure. The development sample contained
34,385 records, corresponding to 22,449 unique patients. The validation
sample containing 14,316 records (9354 unique patients) was set aside
and not used in risk model development.
Defining Episodes of Surgical Management
To obviate ambiguities in assigning short-term outcomes to operations
performed close together in time, we defined 30-day episodes of surgical
management. The first such episode for a patient started with his/her first
surgical operation and was assigned an outcome of alive or dead according
to the vital status of the patient at 30 days. Any reinterventionwithin this 30-
day episodewas not included in model development but was noted as a sec-
ondary outcome of the episode for the purposes of monitoring (not reported
in this article). The patient’s next surgical operationmore than 30 days after
the start of this first episode was treated as the start of a new episode and so
forth. Each episode was treated as independent within the analysis.
Grouping Operations Using the Central Cardiac
Audit Database ‘‘Specific Procedure’’ Algorithm
A combination of up to 8 individual procedural International Paediatric
and Congenital Cardiac Codes (IPCCCs)17 may be submitted to CCAD toThe Journal of Thoracic and Cardescribe each operation. The Steering Committee of CCAD, which includes
experienced pediatric cardiac surgeons and cardiologists, have developed
a specific procedure algorithm that links the combinations of individual
IPCCCs in a record to at most 1 of 36 recognizable operations. The list of
36 operations (hereafter referred to as ‘‘specific procedures’’) includes gen-
erally accepted benchmark operations18 along with others that were deter-
mined by the CCAD Steering Committee between 2000 and 2010. The
algorithm imposes a hierarchy with the record assigned the most complex
specific procedure consistent with the combination of codes submitted.
The 36 specific procedures capture 83% of operations in the data and
center-specific outcomes for these specific procedures have been published
by CCAD on the Internet16 and are well known as a core output of CCAD.
Classification of Primary Diagnosis
Each CCAD record contains up to 6 IPCCC diagnostic codes. To ex-
plore the potential for this information to add discriminatory power to
risk adjustment, we developed a new hierarchical scheme that links the
combination of IPCCC diagnostic codes available for a record to at most
1 of 24 primary cardiac diagnoses. We also identified those combinations
of IPCCCs that indicated that the patient had a functionally univentricular
heart. The process for developing these diagnostic categories is described
in detail by Brown and colleagues.19
Other Factors Considered
Given the planned use of the model in quality assurance, only preoper-
ative factors were considered for inclusion in the risk model. In addition to
specific procedure and diagnostic information, the factors considered on
the basis of potential clinical relevance and availability within the dataset
were year of surgery; whether the procedure was performed on bypass; pa-
tient sex, age, weight; whether there was an antenatal diagnosis; ethnicity;
the Townsend score of socioeconomic deprivationc20; and comorbidity.
IPCCCs defining comorbid conditions were grouped into 4 categories:
premature (gestational age <37 weeks); Down syndrome; congenital
non–Down syndrome comorbidity (all genetic syndromes, clinical constel-
lations of features that constitute a recognized syndrome, and congenital
structural defects of organs other than the heart21); and acquired comorbid-
ity (including preoperative comorbidities acquired as a result of heart dis-
ease or its treatments, eg, renal failure or necrotizing enterocolitis).22 For
a given patient record, comorbid conditions appearing as IPCCCs in any
of the comorbidity or diagnosis fields were classed as comorbidities. We
treated records where no comorbidities were entered as though that patient
did not have any comorbidity.
Missing and Unknown Data
Episodes with missing 30-day outcomewere removed.Weight-for-age z
scores were calculated for each episode on the basis of a subdivision of the
development dataset into 23 age bands (narrower at younger ages). Epi-
sodes in the development set with an absolute z score of 3 or more were
considered infeasible and, along with episodes with missing weights, as-
signed the mean weight of their corresponding age band. To mimic pro-
spective use, no adjustment of weights of this nature was made in the
validation set. Where inconsistencies in any of the data were suspected,
for example, between episodes relating to the same patient, the data were
confirmed with CCAD.
Model Development
After descriptive analyses that were performed to characterize the de-
velopment dataset, univariate 30-day, episode-level mortality rates were
calculated for the candidate preoperative risk factors, with some removed
from consideration on the basis of this univariate analysis. Some risk fac-
tors were removed because of considerations of data completeness.
Multiple logistic regression analysis was conducted within PASW Sta-
tistics 18, Release Version 18.0.0 (SPSS, Inc, 2009, Chicago, Ill), usingdiovascular Surgery c Volume 145, Number 5 1271
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models and to parameterize prespecified models, respectively.23 The area
under the receiver operating characteristic curve (C-index), the Hosmer–
Lemeshow chi-square statistic, and MADCAP charts24 were used to assess
the discrimination and accuracy of the candidate models developed. The
MADCAP charts show cumulative predicted and observed deaths versus
episode number, with episodes ordered by increasing predicted risk, en-
abling visual identification of patterns of systematic over- or underestima-
tion of risk. Comparison of MADCAP charts was used to gauge value
added or lost by adopting different approaches to analyzing variables and
in assessing stability of model parameterization when using different ran-
dom subsets of the development dataset.
Instability of model parameterization across random subsets of the de-
velopment data was taken to indicate a risk of overfitting the data. In these
instances, we simplified variables by reducing the number of categories
and assessed tradeoffs between model performance and stability of
parameterization.
Model development followed an iterative process of multiple logistic re-
gression: assessment of model performance and stability, discussion be-
tween clinicians and analysts, and variable simplification. Ultimately,
model choice was influenced by considerations of uptake by CCAD and
UK centers, as well as statistical performance.
The discrimination and accuracy of the final model were assessed in the
independent validation dataset. For interest, 2 additional models were eval-
uated—one based solely on specific procedure and the other comprising all
factors in the final model except specific procedure.
The distribution of predicted risk in the development and validation sets
was also compared to assess stability of case mix.RESULTS
Development and Validation Sets
A total of 693 episodes with missing 30-day status (90%
of which occurred before 2002) and a further 72 episodes
with missing patient age were removed from the develop-
ment set. A total of 1485 episodes with missing or anoma-
lous patient weight were assigned the mean weight for the
appropriate age. The final development set comprised
26,447 episodes corresponding to 21,610 unique patients.
Of these, 834 episodes (3.2%; confidence interval, 3.0-
3.4) had a 30-day outcome of death. A total of 1181 epi-
sodes contained at least 1 surgical reintervention within
30 days, and 466 episodes contained at least 1 catheter
reintervention.Preliminary Analysis
During preliminary model development, the following
risk factors were eliminated from further consideration be-
cause of levels of missing data: antenatal diagnosis (38%
missing), ethnicity (26%), and the Townsend deprivation
score20 (26%). Patient sex showed no univariate association
with 30-day mortality and was not considered further in
model development.
The association between age and mortality is nonlinear,
and, having explored several options, we chose to include
in the model both continuous age and 3 age bands: neonate
(<30 days), infant (30 days to 1 year), and child (>1 year).
Because of instability across random subsets of the data
(see ‘‘Model Development’’ section), we grouped the 91272 The Journal of Thoracic and Cardiovascular Surspecific procedures with the lowest volumes (all with<70
episodes in the development set) into a ‘‘low-volume’’ spe-
cific procedure group comprising aortic root replacement
(not Ross), aortopulmonary window repair, atrioventricular
septal defect and tetralogy repair, cor triatriatum repair,
multiple ventricular septal defect closure, Senning or
Mustard procedure, Tetralogy with absent pulmonary valve
repair, tricuspid valve replacement, and truncus and inter-
ruption repair. We also grouped those diagnostic categories
with similar mortality rates into low-, medium-, and high-
risk groups (Appendix 1 shows details on the mappings)
and grouped the non–Down syndrome comorbidities to
give a variable indicating the presence of comorbidity other
than Down syndrome (Appendix 2). Down syndrome was
not associated with increased risk.
Applying an initial model that did not include year of sur-
gery showed a clear trend of improvement in risk-adjusted
outcomes over time. We added a binary variable to indicate
whether an episode occurred pre-2007 or from 2007 on-
ward. Although there is no clinical mechanism for such
a threshold effect, it enabled the entire development set to
be used in the model parameterization while also increasing
the likelihood that the model is fit for prospective use.Descriptive Analysis
The observed 30-day mortality rates in the development
and validation sets for those parameters included in the
model are shown in Table 1. Thirty-day mortality for spe-
cific procedures is shown in Figure 1 (development and val-
idation sets). We note that episodes with missing or
anomalous age or weight, or a 30-day status of ‘‘unknown’’
were not included in the calculation of univariate mortality
rates or within model development or evaluation.
To illustrate the value that diagnostic information can
bring to risk adjustment, consider the arterial shunt, one
procedure performed in patients with differing anatomic
substrates. In the development set, the 30-day mortality
for episodes with arterial shunt was 7.1% overall; 12.3%
for those with a univentricular heart versus 5.8% for those
with a biventricular heart; and 4.1%, 7.2%, and 11.4% in
the low-, medium-, and high-risk diagnostic categories,
respectively.Final Risk Model
The final risk factors included in the logistic regression
model were age (both as a continuous measure and as neo-
nate/infant/child bands), weight, specific procedure (includ-
ing a ‘‘low-volume’’ group), procedure type (bypass or
nonbypass), diagnosis group (low, medium, or high risk),
univentricular heart attribute, presence/absence of a re-
corded non–Down syndrome comorbidity, and episode
pre- or post-2007. Details of the regressionmodel are shown
in Appendix 3.gery c May 2013
TABLE 1. Proportional breakdown of episodes within categories for risk factors included in the final model, along with their associated 30-day
mortality
Model parameter
Development set (used for building model) Validation set (used for model evaluation)
Proportion of episodes
(95% CI)
30-d mortality
(95% CI)
Proportion of episodes
(95% CI)
30-d mortality
(95% CI)
Age continuous – Not shown – Not shown
Age band
Neonates 21.1% (20.0-22.2) 6.8% (6.2-7.5) 21.0% (19.4-22.8) 7.8% (6.8-9.0)
Infants 37.2% (36.3-38.2) 3.1% (2.8-3.5) 36.7% (35.2-38.2) 2.5% (2.1-3.0)
Children 41.7% (40.8-42.7) 1.3% (1.1-1.6) 42.3% (40.9-43.8) 1.4% (1.1-1.8)
Weight (continuous) – Not shown – Not shown
Specific procedure – See Figure 1 – See Figure 1
Procedural type
Bypass 74.2% (73.6-74.9) 3.0% (2.8-3.3) 74.8% (73.9-75.8) 3.0% (2.6-3.4)
Nonbypass 25.8% (24.7-26.8) 3.5% (3.1-3.9) 25.2% (23.6-26.9) 3.7% (3.0-4.5)
Diagnostic grouping
Low-risk diagnosis 39.6% (38.7-40.5) 1.2% (1.0-1.5) 39.9% (38.5-41.4) 1.2% (0.9-1.6)
Medium-risk diagnosis 51.4% (50.6-52.3) 3.7% (3.4-4.1) 50.6% (49.3-52.0) 3.8% (3.3-4.4)
High-risk diagnosis 9.0% (7.9-10.2) 9.0% (7.9-10.2) 9.4% (7.8-11.5) 7.9% (6.4-9.8)
Ventricular status
Not univentricular heart 85.2% (84.7-85.7) 2.6% (2.4-2.8) 85.0% (84.3-85.8) 2.5% (2.2-2.9)
Univentricular heart 14.8% (13.8-16.0) 6.8% (6.1-7.7) 15.0% (13.4-16.9) 6.8% (5.7-8.2)
Comorbidities
No comorbidities* 89.0% (88.6-89.4) 2.9% (2.7-3.2) 88.6% (88.0-89.3) 2.9% (2.6-3.3)
At least 1 comorbidity* 11.0% (10.0-12.2) 5.5% (4.7-6.4) 11.4% (9.8-13.4) 4.9% (3.8-6.3)
2007 indicator
Pre-2007 64.4% (63.7-65.2) 3.4% (3.2-3.7) 63.1% (62.0-64.3) 3.1% (2.7-3.5)
2007 onward 35.6% (34.6-36.6) 2.9% (2.5-3.2) 36.9% (35.4-38.4) 3.3% (2.8-3.9)
Overall 100% 3.2% (3.0-3.4) 100% 3.2% (2.8-3.5)
Figures are shown for the development and validation sets after excluding episodes with missing 30-day status. CI, Confidence interval. *Does not include Down syndrome.
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ment set, giving a C-index of 0.78 (indicating reasonable
discrimination) and Hosmer–Lemeshow chi-square of 9.2
(P¼ .325) (indicating no statistically significant differences
between observed and expected number of deaths when cal-
culated in deciles of predicted risk).
Evaluation of the Risk Model
A risk score could be calculated for 95% of episodes in
the validation set: Age was missing in 0.2% of episodes,
and weight was missing in 4.7% of episodes. Thirty-day
outcome was missing in 226 episodes. Among the remain-
ing 10,597 episodes (in 7849 patients), there were 335
deaths within 30 days (3.2%; confidence interval, 2.8-
3.5). A total of 468 episodes included at least 1 surgical re-
intervention, and 181 episodes included at least 1 catheter
reintervention.
Figure 2 is a MADCAP chart showing the performance
of the model across the spectrum of predicted risk in the
validation set. The C-index is 0.77 compared with 0.78 in
the development set. This good discrimination can be
seen in the MADCAP chart with a shallow climb of cu-
mulative observed deaths (stepped line) at low predicted
risk and a steeper climb at high predicted risk. TheThe Journal of Thoracic and CarHosmer–Lemeshow chi-square statistic is 22.7, indicating
that the discrepancies between observed and predicted
mortality in deciles of predicted risk are statistically sig-
nificant (P ¼ .004), which was predominantly due to the
higher than predicted number of deaths in the first and
fourth deciles of predicted risk.
These discrepancies are evident in the portions of the
MADCAP chart where the stepped line climbs at a higher
or lower rate than the smooth line (predicted deaths). The
overall number of predicted deaths was 329.3 compared
with the 335 observed.
Figure 3 shows a receiver operating characteristic curve
that illustrates the additional discriminatory power of diag-
nostic and other patient information: A model based solely
on specific procedure gave a C-index of 0.72, and a model
based on all factors in the final model except specific proce-
dure has a C-index of 0.74 in the validation set.
The risk model is intended for future use in routine mon-
itoring. Given this and the observed improvement in out-
comes over time and our adjustment for this in the model,
it is performance of the model in episodes that occurred dur-
ing or after 2007 that is most informative concerning its fit-
ness for purpose. Figure 4 shows a MADCAP chart of
model performance in episodes occurring after January 1,diovascular Surgery c Volume 145, Number 5 1273
FIGURE 1. Observed 30-daymortality for specific procedures in the development set (circles) and validation set (crosses). The numbers (n) of episodes for
each specific procedure in the development set are listed. The low-volume specific procedure group includes aortic root replacement (not Ross), aortopul-
monary window repair, atrioventricular septal defect and tetralogy repair, cor triatriatum repair, multiple ventricular septal defect closure, Senning or Mus-
tard procedure, tetralogy with absent pulmonary valve repair, tricuspid valve replacement, and truncus and interruption repair. The vertical lines denote the
mean 30-day mortality in the development set (black) and validation set (grey dashed): Note that these are almost identical. Data are ordered in decreasing
30-day mortality for the development set. Note that the Rastelli procedure is defined as an intraventricular left ventricle to aorta tunnel and right ventricle to
pulmonary artery conduit. VSD, Ventricular septal defect; PDA, patent ductus arteriosus; AVR, aortic valve replacement; ASD, atrial septal defect.
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0.81 compared with 0.77 across all years.
Although the model shows better discrimination among
data from 2007 onward, it underestimates risk at the very
high risk end of the spectrum of predicted risk (Figure 4,
right). It is, as a result, less accurate overall in these more
recent data than in the full development set.
The distributions of predicted risk in the development
and validation sets were found to be similar: Approximately
30% of episodes have 1% or less predicted risk of 30-day
mortality, 80% of episodes have 4% or less predicted
risk, and 5% of episodes have a predicted risk of more
than 10%.
DISCUSSION
We have developed a risk model for use in monitoring 30-
day mortality in pediatric cardiac surgery that incorporated
diagnostic information in addition to procedure, age,
weight, and comorbidity. The model shows reasonable ac-
curacy and good discrimination between groups of patients
with high and low mortality, with a C-index of 0.77 when
evaluated across the entire validation data and a C-index1274 The Journal of Thoracic and Cardiovascular Surof 0.81 for post-2007 data. This discrimination is similar
to that of other published risk-adjustment tools from the
same field of practice.15 As we have shown, supplementing
procedural information with diagnostic, age, weight, and
comorbidity characteristics increased the discriminatory
performance of the risk model: The C-index across the en-
tire validation data was 0.72 when only specific procedure
was included.
It has been observed that procedure categories developed
for use in risk adjustment may have incomplete coverage,
leaving some operations excluded from outcome analy-
ses.6,13,15 The empirically based tool for analyzing
mortality, the Society of Thoracic Surgeons European
Association for Cardio-Thoracic Surgery (STS-EACTS)
Congenital Heart Surgery Mortality Score and the STS-
EACTS Congenital Heart Surgery Mortality Categories,
published by the STS and EACTS in 2009, increased the
coverage of records by including 148 types of operation
and using a Bayesian model to adjust for small denomina-
tors.15 As discussed in the ‘‘Materials and Methods’’ sec-
tion, the specific procedure categories reported by CCAD
online16 are well established and accepted within the Unitedgery c May 2013
FIGURE 2. Cumulative deaths among the entire validation set plotted
against episode number with episodes ordered by increasing risk as pre-
dicted by the risk model.
FIGURE 4. Performance of the model in the validation set for all episodes
occurring after January 1, 2007.
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the dataset. No additional subjective procedural complexity
ratings were used. We gathered additional information for
use in mortality predictions by ascertaining cardiac diagno-
sis, which could be allocated to 97.1% of records classed as
‘‘not a specific procedure,’’ the most common diagnosis
(11.6%) being ‘‘acquired.’’
The risk model is intended for future use in routine mon-
itoring of risk-adjusted outcomes within UK pediatric car-
diac centers. It is the performance of the model during orFIGURE 3. Receiver operating characteristic curve for 3 models evalu-
ated in the validation set: the final risk model (C-index ¼ 0.77), a model
based solely on specific procedure (C-index ¼ 0.72), and a model based
on all factors in the final model except specific procedure (C-index of 0.74).
The Journal of Thoracic and Carafter 2007 that is most informative concerning its fitness
for this purpose. In this period, the model was found to un-
derestimate risk at the very high-risk end. This indicates that
risk adjustment based on the current parameterization of the
model will potentially give an unfair assessment of out-
comes at those centers with a high proportion of high-risk
cases. This is an important caveat to interpretation of risk-
adjusted outcomes within and between centers that will
need to be considered as the work is taken forward. It is im-
portant to understand howdifferences in casemix and differ-
ential performance of the risk model in different subgroups
could combine to give an artefactual impression of better or
worse risk-adjusted outcomes at one center compared with
another. This issue is of particular importance, given the
level of scrutiny towhich these types of outcome data are ex-
posed. Although the United Kingdom is currently the only
country that displays unit-specific pediatric cardiac surgical
outcomes of procedures online,16 there has been consider-
able debate of this issue in the professional journals, with
the suggestion that program-level reporting of unit-
specific outcomes across a range of domains may evolve in-
ternationally over the coming years.25,26
There is a need for a rolling program of recalibration for
amodel in routine use to account for anticipated improvements
in outcomes over time27 and any other evolving trends. Poten-
tial limitations of the current model arising from incomplete
data, which tend to reflect the early years of CCADmethodol-
ogy and user commitment to accurate and full data submission,
could also be addressed by future reparameterization. Along-
side a recalibration, a growing volume of records over time
may support a model with a greater number of variables, fordiovascular Surgery c Volume 145, Number 5 1275
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that the completeness of comorbidity data will increase with
time as clinicians perceive the relevance of this information
to risk adjustment. Data quality improvements over time for
antenatal diagnosis and Townsend deprivation score may
allow these factors to be reconsidered.
The next step for this research is to facilitate and evaluate
the near real-time routine risk-adjusted monitoring of 30-
day outcomes in UK centers. Our ambition is to then com-
plement this work on short-term outcomes by analyzing
long-term outcomes among groups of patient defined by
primary cardiac diagnosis, making use of the rich and
unique source of tracked and validated outcomes available
through CCAD. This would provide clinicians with valu-
able data with which to inform patients and caregivers
and to assess services.CONCLUSIONS
A risk model for pediatric cardiac surgery has been devel-
oped that can be used to partially adjust for case mix during
routine monitoring of outcomes to assist quality assurance.
Diagnostic and other patient information were found to add
useful discriminatory power, increasing the amount of clin-
ical data used in the model.
The authors thank Brian Reddy for the early work on the CCAD
dataset at the start of this project and acknowledge the contribution
of the CCAD steering committee, involved stakeholders, and pa-
tient groups for the creation and maintenance of the CCAD, which
is a world-class audit database.References
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DIAGNOSIS TO DIAGNOSIS RISK GROUP
Each CCAD record contains up to 6 IPCCCs. To explore
the potential for this information to adddiscriminatorypower
to risk adjustment, we developed a new hierarchical scheme
that links the combination of IPCCCs available for a record to
at most 1 of 24 primary cardiac diagnoses. The process for
developing these diagnostic categories is described in detail
by Brown and colleagues.19 The mapping is shown of these
24 primary cardiac diagnoses (and the categories ‘‘proce-
dure’’ and ‘‘comorbidity’’) to 1 of 3 diagnosis risk groups
used in the risk model: low, medium, or high risk.gery c May 2013
Primary cardiac diagnosis
Diagnosis
risk group
Hypoplastic left heart syndrome High risk
Functionally univentricular heart Medium risk
Common arterial trunk (truncus arteriosus) Medium risk
TGAþVSD/DORV, TGA type Medium risk
Interrupted aortic arch High risk
TGA (concordant AV and discordant VA connections) and
intact ventricular septum
Medium risk
Pulmonary atresia with an intact ventricular septum High risk
Pulmonary atresiaþVSD (including Fallot type) Medium risk
Atrioventricular septal defect Low risk
Fallot/DORV-Fallot type Low risk
Aortic valve stenosis (isolated) Medium risk
Tricuspid valve abnormality (including Ebstein’s) Medium risk
Mitral valve abnormality (including supravalvar, subvalvar) Medium risk
Totally anomalous pulmonary venous connection Medium risk
Aortic arch obstruction  VSD/ASD Low risk
Pulmonary stenosis Low risk
Subaortic stenosis (isolated) Low risk
Aortic regurgitation Low risk
VSD Low risk
Interatrial communication (ASD) Low risk
Patent ductus arteriosus Medium risk
Miscellaneous congenital Medium risk
Acquired Medium risk
Procedure Low risk
Comorbidity High risk
Noncardiac or uncoded diagnosis Medium risk
CCAD, Central Cardiac Audit Database; IPCCC, International Paediatric and Congen-
ital Cardiac Code; TGA, transposition of the great arteries; VSD, ventricular septal
defect;DORV, double outlet right ventricle; AV, atrioventricular; VA, ventriculoarterial;
ASD, atrial septal defect.
Continued
IPCCC (used in the CCAD)
101512. Meconium aspiration
102002. Preprocedural shock
102003. Preprocedural arrhythmia
102005. Preprocedural acidosis
102006. Preprocedural coagulation disorder
102007. Preprocedural renal failure
102008. Preprocedural renal failure requiring dialysis
102009. Preprocedural septicemia
102012. Preprocedural neurologic impairment
102014. Preprocedural mechanical ventilatory support
102015. Preprocedural mechanical circulatory support
102016. Preprocedural pulmonary hypertension
102017. Preprocedural tracheostomy
102018. Preprocedural seizures
102202. Premature birth
102203. Infant of diabetic mother
102205. Premature birth 32-35 wk
102206. Premature birth<32 wk
102300. Hereditary/noncardiac abnormality not apparent
102304. Hereditary disorder associated with heart disease
110635. Preprocedural complete AV block
140101. Chromosomal anomaly
140103. Trisomy 18, Edwards syndrome
140104. Trisomy 13, Patau syndrome
140105. 45XO, Turner syndrome
140121. 22q11 microdeletion
140200. Syndrome-association with cardiac involvement
140206. DiGeorge sequence
140217. Marfan syndrome
140219. Noonan syndrome
140228. Tuberous sclerosis
140230. Williams syndrome (infantile hypercalcemia)
140232. Fetal rubella syndrome
140266. Alagille syndrome: arteriohepatic dysplasia
140300. Noncardiac abnormality associated with heart disease
140304. Noncardiothoracic vascular abnormality
140305. Psychomotor developmental delay
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DAPPENDIX 2. INTERNATIONAL PAEDIATRIC AND
CONGENITAL CARDIAC CODE COMORBIDITY
MAPPING
Listed are the IPCCCs recorded in the CCAD that are de-
fined in the model as a non–Down syndrome comorbidity.IPCCC (used in the CCAD)
030109. Position or morphology of thoracoabdominal organs abnormal
030305. Tracheobronchial anomaly
030703. Spleen absent (asplenia)
030704. Multiple spleens (polysplenia)
100665. Preprocedural endocarditis
101400. Secondary systemic hypertension
101402. Primary (essential) systemic hypertension
101444. Abdominal aorta aneurysm
101445. Rupture of thoracic aortic aneurysm
101446. Rupture of abdominal aortic aneurysm
101454. Descending aorta dissection and distal propagation (DeBakey type
III/Stanford type B)
101460. Systemic arteritis
101505. Necrotizing enterocolitis
(Continued)
140306. Cystic fibrosis
140307. Congenital diaphragmatic hernia
140308. Tracheoesophageal fistula
140310. Omphalocele
140311. Duodenal stenosis/atresia
140323. Renal abnormality
140329. Thoracic-mediastinal abnormality
140333. Microcephaly
140349. Tracheobronchial malacia
140404. Pectus carinatum
140405. Pectus excavatum
140409. Kyphoscoliosis
140412. Cleft lip or palate
140414. Anterior chest wall (pectus) deformity
140501. Maternal teratogen associated with congenital heart disease
140601. Multiple congenital malformations
160305. Lung disease
161001. Tracheal stenosis
(Continued)
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Continued
i Xi ¼ 1 if condition satisfied (Xi ¼ 0 otherwise) Bi
30 Procedure type ¼ bypass 0.715
31 Diagnosis group ¼ low risk 0.588
32 Diagnosis group ¼ medium risk 0.222
33 Diagnosis group ¼ high risk 0.366
34 Not identified as univentricular heart 0.446
35 No recorded non–Down syndrome comorbidities 0.579
36 Age group ¼ child 0.797
37 Age group ¼ infant 0.157
38 Age group ¼ neonate 0.640
39 Procedure performed pre-2007 0.257
We note that caution is needed when interpreting individual coefficients because these
are not clinically meaningful when taken in isolation of the other risk factors. The pre-
dicted risk comes from the combination of procedure, age, weight, severity of diag-
nosis, and comorbidity information. VSD, Ventricular septal defect; ASD, atrial septal
defect; PDA, patent ductus arteriosus.
Continued
IPCCC (used in the CCAD)
161009. Tracheal disease
163001. Respiratory failure
IPCCC, International Paediatric and Congenital Cardiac Code; CCAD, Central Car-
diac Audit Database; AV, aortic valve.
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DAPPENDIX 3. FINAL LOGISTIC REGRESSION
RISK MODEL
Probability of death within 30 days ¼ 1
1þ eZ , where
Z ¼3:905þ 0:089age0:038weightþ
X39
i¼1
BiXi:
Parameters i ¼ 139 are tabulated below along with their
corresponding regression coefficients,Bi, and the condition
that must be satisfied for Xi ¼ 1 (Xi ¼ 0 otherwise). Note
that patient age must be in units of years and patient weight
in units of kilograms.i Xi ¼ 1 if condition satisfied (Xi ¼ 0 otherwise) Bi
1 Specific procedure ¼ anomalous coronary artery repair 0.583
2 Specific procedure ¼ aortic valvotomy 1.222
3 Specific procedure ¼ arterial switch (for isolated
transposition)
0.417
4 Specific procedure ¼ arterial shunt 1.528
5 Specific procedure ¼ arterial switchþVSD closure 0.508
6 Specific procedure ¼ ASD repair 1.234
7 Specific procedure ¼ atrioventricular septal defect
(complete) repair
0.135
8 Specific procedure ¼ atrioventricular septal defect
(partial) repair
0.995
9 Specific procedure ¼ aortic valve replacement, non-Ross 1.226
10 Specific procedure ¼ aortic valve replacement, Ross 0.376
11 Specific procedure ¼ bidirectional cavopulmonary shunt 0.228
12 Specific procedure ¼ Fontan procedure 0.536
13 Specific procedure ¼ interrupted aortic arch repair 0.721
14 Specific procedure ¼ isolated coarctation repair 0.135
15 Specific procedure ¼ isolated pulmonary artery band 1.399
16 Specific procedure ¼ low-volume group 0.879
17 Specific procedure ¼ mitral valve replacement 1.602
18 Specific procedure ¼ no specific procedure 1.114
19 Specific procedure ¼ Norwood procedure (stage 1) 1.171
20 Specific procedure ¼ PDA ligation (surgical) 0.640
21 Specific procedure ¼ pulmonary atresia VSD repair 1.191
22 Specific procedure ¼ pulmonary valve replacement 0.916
23 Specific procedure ¼ Rastelli procedure 16.501
24 Specific procedure ¼ repair of total anomalous pulmonary
venous drainage
0.638
25 Specific procedure ¼ subvalvar aortic stenosis repair 0.789
26 Specific procedure ¼ supravalvar aortic stenosis repair 0.520
27 Specific procedure ¼ truncus arteriosus repair 0.902
28 Specific procedure ¼ tetralogy repair 0.783
29 Specific procedure ¼ VSD repair 0.139
(Continued)
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cation will always be available from the University College
London Clinical Operational Research Unit Web site
(http://www.ucl.ac.uk/operational-research/AnalysisTools/
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